HINJ Member Companies Donate $11.1 Million for Hurricane Sandy Relief Efforts
New Brunswick, NJ, November 28, 2012 — Responding to the needs of people and communities throughout New Jersey and the region impacted by Hurricane Sandy, member companies of the HealthCare Institute of New Jersey (HINJ) have donated, to date, approximately $11.1 million in cash contributions and product donations. This figure does not include employee contributions […]
HINJ Member-Company Researchers Honored with 2012 Edison Patent Awards
Bristol-Myers Squib, Merck Research Laboratories and Immunomedics Honored by R&D Council of NJ New Brunswick, NJ, November 9, 2012 — Researchers from three HealthCare Institute of New Jersey (HINJ) member companies last evening were recognized for their breakthrough research and awarded the prestigious Edison Patent Award from the Research & Development Council of New Jersey.
HINJ Joins ‘Building Our Future’ Coalition in Support of Investment in New Jersey Higher Education
New Brunswick, NJ, October 8, 2012 — On the Rutgers University campus this morning, HealthCare Institute for New Jersey (HINJ) President and Chief Executive Officer Dean J. Paranicas joined former Governor Tom Kean, Senate President Steve Sweeney, Speaker Sheila Y. Oliver, Rutgers President Dr. Robert L. Barchi, and other state business leaders, higher education officials […]
Rutgers President Robert L. Barchi Addresses HINJ Board of Trustees
New Brunswick, NJ, September 21, 2012 — Dr. Robert L. Barchi, the new president of Rutgers, the State University of New Jersey, addressed the HealthCare Institute of New Jersey (HINJ) Board of Trustees on September 19 in Rutgers’ historic Winants Hall.
HINJ Announces New Board and Steering Committee Leadership
Novartis Executive Kevin T. Rigby Named Board Chair New Brunswick, NJ, July 16, 2012 ― The HealthCare Institute of New Jersey (HINJ) has announced the new officers of its Board of Trustees as well as the leadership of its Steering Committee.
HINJ Applauds Enactment of FDA User Fee Reauthorization Law
New Brunswick, NJ, July 10, 2012 ― The HealthCare Institute of New Jersey (HINJ) applauds the enactment of the Food and Drug Administration Safety and Innovation Act of 2012 (S. 3187), which includes the reauthorization of the Prescription Drug User Fee Act (PDUFA) and the Medical Device User Fee Act (MDUFA). President Obama signed the […]
HINJ’s Statement Regarding the U.S. Supreme Court’s Ruling on the Patient Protection and Affordable Care Act
New Brunswick, NJ, June 28, 2012 ― The HealthCare Institute of New Jersey (HINJ) has issued the following statement regarding the ruling today by the Supreme Court of the United States pertaining to the Patient Protection and Affordable Care Act of 2010.
HINJ Applauds Senate and House on Passage of FDA User Fee Reauthorizations
New Brunswick, NJ, June 1, 2012 ― The HealthCare Institute of New Jersey (HINJ) applauds the overwhelming, bipartisan approval by the United States Senate and House of Representatives of legislation that included the reauthorization of the Prescription Drug User Fee Act (PDUFA) and the Medical Device User Fee Act (MDUFA).
HINJ President & CEO Discusses State of Industry on ‘New Jersey Capitol Report’
New Brunswick, May 18, 2012―Appearing on New Jersey Capitol Report with anchors Steve Adubato and Rafael Pi Roman, HealthCare Institute of New Jersey (HINJ) President and Chief Executive Officer Dean J. Paranicas discussed the current state of the life sciences industry in New Jersey, which he summed up as “encouraging.”
HealthCare Institute of New Jersey Names Douglas Berger Director of Communications
New Brunswick, NJ, May 15, 2012 ― The HealthCare Institute of New Jersey (HINJ) has appointed Douglas Berger as its Director of Communications. In this role, Berger will oversee all aspects of HINJ communications, including member communications, public relations, and social media.